FDA approves Vera Therapeutics kidney disease treatment
Reported bySTAT News ↗·Sourced by Goodlede
The FDA approved Trutakna from Vera Therapeutics to treat IgA nephropathy (IgAN), a chronic autoimmune kidney disease that causes progressive loss of kidney function and potentially organ failure requiring dialysis.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at STAT News
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Science
Incredible new material makes heat programmable
ScienceDaily · Verified
Environment
This champion soccer team teaches fans about climate change and DEI. They've sold out every game
GoodGoodGood · Verified
Kindness
Mamdani promised public grocery stores. Now he's opening NYC's first city-funded pet food pantry, too
GoodGoodGood · Verified